Zosurabalpin discovery Tethered macrocyclic peptides represent a promising new class of antibiotics, distinguished by their unique structure and potent activity against highly resistant bacteria.Discovery of RG6006, a Tethered Macrocyclic Peptide This innovative approach in drug discovery has garnered significant attention, particularly with the development of Zosurabalpin, a leading example that targets carbapenem-resistant *Acinetobacter baumannii* (CRAB).Antibacterial macrocyclic peptides reveal a distinct mode ... These compounds are designed to overcome the limitations of existing antibiotics by employing novel mechanisms of action, offering a critical new weapon in the escalating fight against antimicrobial resistance.
Macrocyclic peptides, by definition, are cyclic molecules composed of amino acids linked by peptide bonds. The "tethered" aspect refers to a specific structural modification where an additional chemical moiety is attached to this macrocyclic core.Zosurabalpin: an antibiotic with a new mechanism of action ... This tethering can influence the molecule's properties, such as its stability, solubility, and importantly, its ability to interact with bacterial targets.Discovery of RG6006, a Tethered Macrocyclic Peptide This structural distinctiveness sets tethered macrocyclic peptides apart from more traditional antibiotic classes and contributes to their unique modes of action.
The rise of antimicrobial resistance (AMR) poses a severe global health threat.Zosurabalpin TFA is atethered macrocyclic peptide antibiotic, acting specifically on A. baumannii. Zosurabalpin TFA inhibits lipopolysaccharide-transport. Bacteria are evolving at an alarming rate, developing resistance to even the most powerful antibiotics.作者：WJ Wang·2024·被引用次数：10—Recently, two companion papers published in Nature reported a first-in-classtethered macrocyclic peptide antibiotictargeting carbapenem- ... Infections caused by multidrug-resistant organisms (MDROs), such as CRAB, are becoming increasingly difficult to treat, leading to higher mortality rates and prolonged hospital stays.作者：JR Randall·2023·被引用次数：1—The peptide library is tethered to the outer membranevia a transmembrane domain and the linker is long enough to allow peptides to reach potential periplasmic ... The discovery and development of novel antibiotic classes, like tethered macrocyclic peptides, are therefore crucial to addressing this growing crisis.
Zosurabalpin has emerged as a flagship compound within the tethered macrocyclic peptide classnovel antibiotics that works against highly resistant bacteria. It demonstrates remarkable efficacy against CRAB, a pathogen notorious for its resistance to carbapenems, a last-resort class of antibiotics.Now, investigators report early-stage research ontethered macrocyclic peptide (MCP) antibioticswith potent activity against CRAB, culminating in the ... Zosurabalpin's success lies in its novel mechanism of action, which involves inhibiting the transport of lipopolysaccharide (LPS) across the bacterial membrane. LPS is a critical component of the outer membrane in Gram-negative bacteria, and its proper assembly is essential for bacterial survival. By disrupting this process, Zosurabalpin effectively compromises the integrity of the bacterial cellZosurabalpin:a novel tethered macrocyclic peptide antibioticthat kills carbapenem-resistant. Acinetobacter baumannii. MedComm (2020). 2024 Aug 11;5(8):e696 ....
The detailed mechanism by which tethered macrocyclic peptides like Zosurabalpin operate is a key area of research. These compounds are understood to disrupt the LptB2FGC complex, a vital machinery responsible for translocating LPS from the inner to the outer membrane in Gram-negative bacteria. This disruption leads to the accumulation of LPS in the periplasm, ultimately destabilizing the outer membrane and leading to bacterial cell death. This targeted approach offers a distinct advantage over antibiotics with more general mechanisms, potentially leading to fewer off-target effects and reduced development of resistance.
The identification of tethered macrocyclic peptides often involves extensive screening of large compound libraries. Techniques such as display technologies, where peptide libraries are tethered to cellular components, have played a role in discovering novel candidates. Researchers have screened tens of thousands of compounds to identify promising leads like ZosurabalpinUsing display technologies to identify macrocyclic peptide .... The development process then involves optimizing these initial discoveries for potency, safety, and pharmacokinetic properties, moving them through preclinical and clinical trials.
While the discovery of tethered macrocyclic peptides like Zosurabalpin is a significant advancement, challenges remain. The journey from laboratory discovery to an approved drug is long and complex, involving rigorous testing for efficacy and safety in human trials. Understanding the potential for resistance development against these new agents and ensuring their accessibility globally will be critical as they progress2024年1月6日—Here we report the identification and optimization oftethered macrocyclic peptide (MCP) antibioticswith potent antibacterial activity against .... Nonetheless, tethered macrocyclic peptides represent a vital new direction in the ongoing effort to combat the ever-evolving threat of antibiotic-resistant bacteria.
Join the newsletter to receive news, updates, new products and freebies in your inbox.